down arrow

Samrat Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
258.85
6.55 (2.6%)
BSENSE

Dec 05

BSE+NSE Vol: 283

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Concord Drugs
Sunil Healthcare
Source Natural
Ajooni Biotech
Samrat Pharma
Makers Labs.
Rajnish Wellness
Bharat Immunolog
Amwill Health
Asston Pharmaceu
Kabra Drugs
Why is Samrat Pharmachem Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
2
Flat results in Sep 25
  • OPERATING CF(Y) Lowest at Rs -10.09 Cr
  • PBDIT(Q) Lowest at Rs -0.36 cr.
  • OPERATING PROFIT TO NET SALES (Q) Lowest at -0.46%
3
With ROE of 2.2, it has a Very Expensive valuation with a 1.1 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -37.02%, its profits have fallen by -75.9%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -37.02% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Samrat Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Samrat Pharma
-37.02%
-0.84
43.82%
Sensex
4.86%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.26%
EBIT Growth (5y)
-9.88%
EBIT to Interest (avg)
12.29
Debt to EBITDA (avg)
1.80
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
3.88
Tax Ratio
48.17%
Dividend Payout Ratio
4.34%
Pledged Shares
0
Institutional Holding
3.24%
ROCE (avg)
21.43%
ROE (avg)
16.23%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
50
Industry P/E
34
Price to Book Value
1.10
EV to EBIT
20.61
EV to EBITDA
17.15
EV to Capital Employed
1.12
EV to Sales
0.24
PEG Ratio
NA
Dividend Yield
0.40%
ROCE (Latest)
5.41%
ROE (Latest)
2.21%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DPS(Y)

Highest at Rs 1.00

NET SALES(Q)

Highest at Rs 78.87 cr

-6What is not working for the Company
OPERATING CF(Y)

Lowest at Rs -10.09 Cr

PBDIT(Q)

Lowest at Rs -0.36 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -0.46%

PBT LESS OI(Q)

Lowest at Rs -0.80 cr.

EPS(Q)

Lowest at Rs -1.91

Loading Valuation Snapshot...
Here's what is working for Samrat Pharma
Net Sales - Quarterly
Highest at Rs 78.87 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Dividend per Share (DPS) - Annually
Highest at Rs 1.00
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (Rs)

Here's what is not working for Samrat Pharma
Operating Cash Flow - Annually
Lowest at Rs -10.09 Cr
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.36 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -0.46%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.80 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -1.91
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."